Gut Immune Cells May Help Send Multiple Sclerosis Into Remission
An international research team led by UCSF scientists has shown, for the first time, that gut immune cells travel to the brain during multiple sclerosis flare-ups in patients.
University of California San Francisco
Give to UCSF
Displaying 151 - 180 of 299
-
-
11 UCSF Research Specialties Rank in Top 10 in US News Global Universities Rankings for 2021
Now in their seventh year, the Best Global Universities rankings focus on schools’ academic research and reputation overall instead of specific undergraduate and graduate programs. These global rankings help the increasing number of students exploring international higher education options to more accurately compare institutions around the world.
-
Cancer Immunotherapy ‘Uniquely Suppressed’ by Liver Tumors
Though cancer immunotherapy has become a promising standard-of-care treatment – and in some cases, perhaps a cure – for a wide variety of different cancers, it doesn’t work for everyone, and researchers have increasingly turned their attention to understanding why.
-
UCSF Researchers Test New COVID-19 Drug
-
Do Masks Provide a Just-Right Dose of Coronavirus?
Infectious diseases expert Monica Gandhi, MD, MPH, explores her hypothesis that one of the benefits of masks may be that they provide exposure to enough coronavirus to build immunity but not enough to cause illness.
-
To Treat Frontotemporal Dementia, Treat the Brain’s Immune Cells
Though FTD is not as well known as Alzheimer’s disease, it’s the second most common cause of dementia in people under 65, and there’s currently no treatment.
-
Immune Cells in Spinal Fluid of Multiple Sclerosis Patients Identified as Likely Disease Drivers
New UCSF research sheds light on how immune system B cells that infiltrate the central nervous system may drive multiple sclerosis.
-
In Tiny Llama Antibodies, Researchers See Hope for a Coronavirus Treatment
-
How COVID Sends Some Bodies to War With Themselves
-
COVID-19 Frontliners: Searching for the Silver Bullet
Clinical trial leader Annie Luetkemeyer, MD, tests promising therapies for COVID-19 – and soon a vaccine.
-
Tweeting a Pandemic
How I learned to use social media to advance the public’s understanding of COVID-19.
-
How to Build a COVID Testing Lab in Eight Days
As the United States’ testing regime floundered early in the pandemic, scientists at UCSF and the Chan Zuckerberg Biohub created from scratch a diagnostic lab that became a model for the nation.
-
We Must Learn from Our Past
A look at past outbreaks offers guidance on bringing the current one to an end – and on thwarting the next one.
-
Seeking Immunity Against COVID-19
Joel Ernst, MD, addresses key questions about how vaccine development works and why vaccines are especially important in the case of COVID-19.
-
We Thought It Was Just a Respiratory Virus
UCSF researchers are taking a closer look at COVID-19’s dizzying array of symptoms to get at the disease’s root causes.
-
Living With COVID-19 When It Won't Go Away
-
UCSF, St. Jude Identify Key Culprit Driving Treatment Resistance in Deadly Immune Disorder
The finding could offer additional insights into other immune conditions, including a type of childhood leukemia and the severe inflammation response in some children with COVID-19.
-
Rare, Super Coronavirus Antibodies Likely to Yield Vaccine, Say Stanford, UCSF Experts
-
Tumors Disrupt the Immune System Throughout the Body
Depending on a cancer’s tissue of origin, tumors cause widespread and variable disruption of the immune system throughout the body, not just at the primary tumor site.
-
UCSF Cancer Researchers Present New Advances at ASCO 2020
Cancer specialists from UCSF will present new research findings at the annual scientific program of the American Society of Clinical Oncology, the world’s largest clinical cancer research meeting.
-
The Disappointing Truth About Antibody Testing
-
Flipping A Genetic Switch on Cells Lets Researchers Boost or Suppress Immune Responses
Cancer and autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, might not seem to have much in common, but some researchers now are pinning hopes on the same immune system cell –
-
Testing the Tests: COVID-19 Antibody Assays Scrutinized for Accuracy by UCSF, UC Berkeley Researchers
A project launched by UC San Francisco and UC Berkeley scientists evaluated some of the more than 120 available antibody test kits.
-
Coronavirus Antibody Tests: Can You Trust the Results?
-
Two Drugs Studied in Bay Area Could Lessen Coronavirus Deaths, Hospitalizations
-
CRISPR-Based ‘Discovery Engine’ for New Cell Therapies to Advance Cancer Treatments
UCSF researchers now have reported a new method to design and test cell therapies, one they expect will speed the development of new life-saving treatments not only for cancer, but for other diseases, too.
-
Urine Test Can Detect Likelihood of Kidney Transplant Rejection
A simple urine test can diagnose and predict acute rejection in kidney transplants, leading to an opportunity for earlier detection and treatment, according to a new study by researchers at UCSF.
-
Coronavirus: UCSF expert working on quicker diagnostic test to stop spread
-
Newborn Immune System Detects Harmful Skin Bacteria
UCSF scientists found that an early-life window of immune tolerance available to a normally harmless bacterial species is firmly closed to another, often pathogenic species — one that is a leading cause of drug-resistant skin infections in the U.S. and occasional source of “flesh-eating” necrosis.
-
Researchers Halt Spread of Breast Cancer by Blocking Metastasis-Promoting Enzyme
In a breakthrough with important implications for the future of immunotherapy for breast cancer, UCSF scientists have found that blocking the activity of a single enzyme can prevent a common type of breast cancer from spreading to distant organs.